Performance of activities focused towards in vitro expression, detection and monitoring of antigen targets derived from both standard and novel expression platforms without supervision. Responsible for both technical and communication roles for his/her function to associated project core teams. Designs and executes non-routine experiments on a basis of literature analyses with minimal supervision. Supervise/train technicians and junior scientists. The primary scope of responsibility is within the immediate function and secondarily within a multi-disciplinary project team.
Conduct vaccine research for bacterial diseases of swine that provide solutions including novel entities for treatment and control of bacterial diseases associated with bacteria.
As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies’ success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim’s high regard for our employees.
The Senior Clinical Research Associate (Sr. CRA) is responsible for the execution and control of Clinical R&D study programs in alignment with Clinical Scientists and line managers. In addition, the Sr. CRA may lead other CRAs and Study Coordinators, being accountable for the quality and consistency of the CRA team deliverables or collectively positioning the knowledge and expertise within the study teams. The Sr. CRA is a crucial member of study teams and provides key direction in the initiation, organization, conduct and reporting of on-site and off-site (national and global) clinical studies for all animal species. This comprises interaction with CROs/Investigators, monitoring of study status, quality control and integrity of data, management of study data and procedures in compliance to GxP and relevant regulatory guidelines. The incumbent also circulates documents for approval, drafts study documents and reports, assists with study in-life phase, may perform on-site investigator and monitoring of studies, designs and implements study related processes and is responsible for the closure of studies including preparation of archiving.
The Senior Clinical Research Monitor will perform the same duties as the Clinical Res. Monitor with the addition of other clinical duties consisting of, but not limited to, protocol development, planning, implementation , conduct/oversight, clinical study management, study budgets, and some CRO management and reporting.
For complex multi site (GCP) studies, the incumbent will assume the Lead Monitor role.
Provide support to AH Innovation Division through coordinating key initiatives as well as execution of activities aligned with AH Innovation Division strategy and in support of identified business needs, goals and objectives including site responsibility, site travel support, purchasing and sourcing, budgeting support, employee development and training initiatives, etc. Work involves the application of independent thinking, the ability to work autonomously and make decisions using sound judgment. Operates with a moderate degree of independence under a more senior leadership.
To lead vaccine research for viral diseases of swine, including discovery of newly emerging swine viruses and providing guidance for rapid disease control response in collaboration with the transboundary and emerging viral disease team.
To build an unparalleled external network to ensure rapid adoption of relevant new technologies and ensure that BI is the preferred partner when external researchers develop new platform technologies or novel sub-unit-based vaccine candidates.
The position is accountable for building a brand new team of bacterial scientists based in Ames, Iowa. The incumbent will be responsible for developing and managing the Bacterial Disease Research Strategic Plan in collaboration with all other Innovation Division (ID) functions (BIAH, BI Human Pharma and external collaborators) aligned with ID governance processes, and the long term Animal Health business strategy. This strategy will have lasting impact on the overall portfolio value. The bacterial disease research team led by the incumbent will identify and develop ways for the control of bacterial diseases, in veterinary species. The incumbent is accountable for the discovery and development of novel entities, as well as the initiation and support of opportunities for life cycle management, prevention and control of bacterial diseases. As part of the AH Research Leadership Team, the incumbent is expected to contribute to the strategic direction and leadership of AH Research activities. The incumbent will also lead and manage the appropriate life cycle management activities collaborating with global strategic marketing.